2022 FDA Forum — Current Developments in Food, Drug and Device Law

Andrew Jackson moderated the Drug & Device Panel — which included counsel from Coloplast Corp., Roche Diagnostics Corp. and Novo Nordisk — in a discussion of recent regulatory and litigation challenges and developments in the drug and medical device industries from an insider's perspective. The panel was part of the 2022 FDA Forum — Current Developments in Food, Drug and Device Law, presented by the Minnesota State Bar Association (MSBA).